North America Legal Cannabis Market

North America Legal Cannabis Market Size, Share, Growth Analysis, By Source(Marijuana, Flowers), By Derivative(CBD, THC), By End - Use(Medical Use, Chronic Pain) - Industry Forecast 2024-2031


Report ID: SQMIR35I2333 | Region: Regional | Published Date: February, 2024
Pages: 157 | Tables: 110 | Figures: 76

North America Legal Cannabis Market Insights

North American Legal Cannabis Market size was valued at USD 15.50 Billion in 2022 and is poised to grow from USD 17.83 Billion in 2023 to USD 54.53 Billion by 2031, at a CAGR of 15% during the forecast period (2024-2031). 

The legal cannabis industry has been significantly shaped by North America, especially the United States and Canada. Significant numbers of states in both countries have legalized cannabis for recreational use in addition to sanctioning its use for medical purposes. This increase in acceptance can be ascribed to cannabis' superior effectiveness in treating chronic illnesses compared to conventional therapies, which has led to a noticeable increase in the local market.

Cannabis is used in a variety of ways – in oils, tinctures, dried flowers, or buds. A lot of the time, it is used to stop or lessen epileptic convulsions. It is a sought-after treatment for persistent pain management in illnesses like multiple sclerosis and HIV/AIDS because the active ingredients, CBD and THC, act on the pain receptors and inhibit signal transmission.

Cannabidiols, or the active substances in cannabis, have received a scant amount of thorough research on their effects and processes, but its acceptance as an alternative treatment option is growing.

Growth in the cannabis industry is anticipated as a result of governmental efforts to control the illegal drug trade. The MORE (Marijuana Opportunity, Reinvestment, and Expungement) Act's reappearance in the U.S. House of Representatives serves as an excellent example.

If this proposal is approved, it might end the federal ban of cannabis and promote decriminalization. From an economic standpoint, adult use legalization promises to increase employment and significantly boost the economy across a number of industries, including travel, real estate, banking, food, and transportation. This upcoming change in law is expected to increase the number of people who use cannabis legally and decrease the existence of the black market, supporting the expansion of the legal business in North America.

$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

North American Legal Cannabis Market size was valued at USD 15.50 Billion in 2022 and is poised to grow from USD 17.83 Billion in 2023 to USD 54.53 Billion by 2031, at a CAGR of 15% during the forecast period (2024-2031). 

The North American legal cannabis market is a dynamic marketplace with a wide range of competitors, from well-known industry titans to innovative entrepreneurs. Since this market's growth curve has received a lot of attention, more people are competing to find their niches. 'Canopy Growth Corporation (Canada)', 'Aurora Cannabis Inc. (Canada)', 'Curaleaf Holdings, Inc. (United States)', 'Cronos Group Inc. (Canada)', 'Tilray, Inc. (Canada)', 'Green Thumb Industries Inc. (United States)', 'Aphria Inc. (Canada)', 'Trulieve Cannabis Corp. (United States)', 'Cresco Labs Inc. (United States)', 'Harvest Health & Recreation Inc. (United States)', 'TerrAscend Corp. (Canada)', 'The Green Organic Dutchman Holdings Ltd. (Canada)', 'HEXO Corp. (Canada)', 'Vireo Health International, Inc. (United States)', 'OrganiGram Holdings Inc. (Canada)', 'Charlotte's Web Holdings, Inc. (United States)', 'Harborside Inc. (Canada)', 'MedMen Enterprises Inc. (United States)', 'Valens Company Inc. (Canada)', 'Village Farms International, Inc. (Canada)'

The expansion of the legal cannabis market in North America has been largely attributed to favorable government laws and partial legalization of cannabis for adult-use recreational and medical purposes in both the United States and Canada.

Product Diversification: Numerous product developments are being made for the legal cannabis industry, including a variety of consumption styles, strength levels, and derivative goods that appeal to different user tastes.

The development of the regional industry has been greatly assisted by the favorable regulatory frameworks and the partial legalization of cannabis in the United States and Canada for adult (recreational) as well as medical purposes. The United States was the major contributor in 2022, generating an enormous 86.7% of the total revenue. The regional market's expansion is attributed to a number of factors, including the geographic concentration of major marijuana producers. The U.S. government's accommodating approach and the continuous movement in favor of medical marijuana legalization suggest that the country's leading revenue share will continue to grow, solidifying its market position for the foreseeable future. Additionally, the 2018 Farm Bill's crucial passage, which effectively legalizes hemp and products produced from it across the U.S., is a key factor driving the popularity of these goods.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

North America Legal Cannabis Market

Product ID: SQMIR35I2333

$3,500
BUY NOW GET FREE SAMPLE